Notes and references
1 (a) A. H. Merrill, Jr. and C. C. Sweeley, Biochemistry of Lipids,
Lipoproteins and Membranes, ed. D. E. Vance and J. E. Vance, Elsevier
Science, Amsterdam, 1996, ch 12, pp. 309–339; (b) J. Liao, J. Tao, G. Lin
and D. Liu, Tetrahedron, 2005, 61, 4715; Y. A. Hannun, J. Biol. Chem.,
1994, 269, 31251; (c) T. Kolter and K. Sandhoff, Angew. Chem., Int. Ed.,
1999, 38, 1532; (d) R. C. Dickson, Annu. Rev. Biochem., 1998, 67, 27; (e)
T. Kolter and K. Sandhoff, Chem. Soc. Rev., 1996, 371; (f) Y. A. Hannun
and R. M. Bell, Science, 1989, 243, 500.
2 (a) C. A. Welsch, L. W. A. Roth, J. F. Goetschy and N. R. Movva,
J. Biol. Chem., 2004, 279, 36720; (b) M. T. Park, J. A. Kang, J. A. Choi,
C. M. Kang, T. H. Kim, S. Bae, S. Kang, S. Kim, C. I. Choi, C. K. Cho,
H. Y. Chung, Y. S. Lee and S. J. Lee, Clin. Cancer Res., 2003, 9, 878; (c)
T. Natori, M. Morita, K. Akimoto and Y. Koezuka, Tetrahedron, 1994,
50, 2771; (d) J. Turinsky and G. W. Nagel, Biochem. Biophys. Res.
Commun., 1992, 188, 358; (e) M. Honda, Y. Ueda, S. Sugiyama and
T. Komori, Chem. Pharm. Bull., 1991, 39, 1385; (f) S. Dharmawardhane,
B. Rubinstein and A. I. Stern, Plant Physiol., 1989, 89, 1345; (g)
A. H. Merrill, Jr., S. Nimkar, D. Menaldino, Y. A. Hannun, C. Loomis,
R. M. Bell, S. R. Tyagi, J. D. Lambeth, V. L. Stevens, R. Hunter and
D. C. Liotta, Biochemistry, 1989, 28, 3138.
3 (a) K. Takamatsu, M. Mikami, K. Kikuchi, S. Nozawa and
M. Iwamori, Biochim. Biophys. Acta, 1992, 1165, 177; (b) P. W. Wertz,
M. C. Miethke, S. A. Long, J. S. Strauss and D. T. Downing, J. Invest.
Dermatol., 1985, 84, 410; (c) K. A. Karlsson, Acta Chem., Scand., 1964,
18, 2395; (d) K. A. Karlsson, Acta Chem., Scand., 1964, 18, 2397; (e)
K. A. Karlsson, B. E. Samuelsson and G. O. Steen, Acta Chem., Scand.,
1968, 22, 1361; (f) K. Okabe, R. W. Keenan and G. Schmidt, Biochem.
Biophys. Res. Commun., 1968, 31, 137; (g) Y. Barenholz and S. Gatt,
Biochem. Biophys. Res. Commun., 1967, 27, 319; (h) D. E. Vance and
C. C. Sweeley, J. Lipid Res., 1967, 8, 621.
Scheme 3 Conversion of dihydroxyaziridine (3Aa) to D-ribo-phyto-
sphingosine (1). Reagents and conditions: (i) (1) AcOH, CH2Cl2; (2)
KOH, EtOH, rt, 93%; (ii) Pd(OH)2, H2(g) 100 psi, EtOH, rt, 92%; (iii)
Pd(OH)2, H2(g) 100 psi, EtOH, rt, (Boc)2O, 95%; (iv) acetic anhydride,
pyridine, rt, 98%.
4 (a) M. Lombardo, M. G. Capdevila, F. Pasi and C. Trombini,
ˇ
Org. Lett., 2006, 8, 3303; (b) D. Enders, J. Palecek and C. Grondal,
Chem. Commun., 2006, 655; (c) D. Y. Jung, S. Kang, S. B.
Chang and Y. H. Kim, Synlett, 2005, 14, 2183; (d) X. Lu, H. S. Byun
and R. Bittman, J. Org. Chem., 2004, 69, 5433; (e) S. Raghavan and
A. Rajender, J. Org. Chem., 2003, 68, 7094; (f) H. Y. Chiu,
D. L. M. Tzou, J. N. Patkar and C. C. Lin, J. Org. Chem., 2003, 68,
5788; (g) S. Raghavan, A. Rajender and J. S. Yadav, Tetrahedron:
Asymmetry, 2003, 14, 2093; (h) A. J. Ndakala, M. Hashemzadeh,
R. C. So and A. R. Howell, Org. Lett., 2002, 4, 1719; (i) T. Nakamura
and M. Shiozaki, Tetrahedron, 2001, 57, 9087; (j) L. He, H. S. Byun and
R. Bittman, J. Org. Chem., 2000, 65, 7618; (k) C. Martin, W. Pru¨nck,
M. Bortolussi and R. Bloch, Tetrahedron: Asymmetry, 2000, 11, 1585; (l)
O. Shirota, K. Nakanishi and N. Berova, Tetrahedron, 1999, 55, 13643;
(m) R. Imashiro, O. Sakurai, T. Yamashita and H. Horikawa,
Tetrahedron, 1998, 54, 10657.
the basic ring nitrogen of the aziridine and was also used as the
source of the acetate nucleophile to attack the less sterically
hindered C-3 position of the aziridine.5 Finally, enantiomerically
pure D-ribo-phytosphingosine 1 was obtained by palladium
catalyzed debenzylation reaction. We further synthesized and
characterized N-Boc derivative 5 and tetraacetate 6 to confirm
the absolute configuration of the C-3 and C-4 hydroxy group in
D-ribo-phytosphingosine.
5 Y. M. Yun, T. B. Sim, H. S. Hahm, W. K. W. K. Lee and H.-J. Ha,
J. Org. Chem., 2003, 68, 7675.
In summary, we efficiently synthesized enantiomerically pure
D-ribo-phytosphingosine through a five-step sequence in 62%
overall yield from commercially available (2S)-hydroxymethylazir-
idine using asymmetric dihydroxylation of the Z-vinylaziridine as
the key step. This methodology also provides an efficient way for
the preparation of structurally modified phytosphingosine analogs.
Additional study regarding the relation between the stereo-
selectivity in the dihydroxylation and the chain length of the
substituents will be reported in due course.
6 (a) H.-J. Ha, M. C. Hong, S. W. Ko, Y. W. Kim, W. K. Lee and J. Park,
Bioorg. Med. Chem. Lett., 2006, 16, 1880; (b) J. W. Kim, Y. W. Kim,
Y. Inagaki, Y. A. Hwang, S. Mitsutake, Y. W. Ryu, W. K. Lee,
H.-J. Ha, C. S. Park and Y. Igarashi, Bioorg. Med. Chem., 2005, 13,
3475.
7 W. K. Lee and H.-J. Ha, Aldrichimica Acta, 2003, 36, 57.
8 V. Kumar and S. Dev, Tetrahedron, 1987, 43, 5933.
9 R. Imashiro, O. Sakurai, T. Yamashita and H. Horikawa, Tetrahedron,
1998, 54, 10657–10670.
10 (a) H. C. Kolb, M. S. VanNieuwenhze and K. B. Sharpless, Chem. Rev.,
1994, 94, 2483; (b) M. Tokles and J. K. Snyder, Tetrahedron Lett., 1986,
27, 3951.
11 (a) K. D. Lee, J. M. Suh, J. H. Park, H.-J. Ha, H. G. Choi, C. S. Park,
J. W. Chang, W. K. Lee, Y. Dong and H. Yun, Tetrahedron, 2001, 57,
8267; (b) Y. Dong, Y. H. Yun, C. S. Park, W. K. Lee and H.-J. Ha,
Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 2003, 59, 659; (c)
H.-Y. Noh, S. W. Kim, S. I. Paek, H.-J. Ha, H. Yun and W. K. Lee,
Tetrahedron, 2005, 61, 9281.
This work was supported by the following institutions:
The Korea Science and Engineering Foundation (R01-2005-000-
10032-0 and the Center for Bioactive Molecular Hybrids to
HJH), Korea Research Foundation (KRF-2002-070-C00060 to
WKL) and Imagene for providing enantiomerically pure chiral
aziridines.
This journal is ß The Royal Society of Chemistry 2007
Chem. Commun., 2007, 79–81 | 81